China has administered over 31 million doses of COVID-19 vaccines
Share - WeChat


China has administered over 31 million doses of COVID-19 vaccines for key groups as of Wednesday.
China granted conditional market approval for its first COVID-19 vaccine on Dec 30, but vaccines in the last stage of clinical trials have been available for emergency use in the country since June. By the end of December, 14 COVID-19 vaccines developed by China were under clinical trials, including five in phase 3, the final trial before a vaccine is approved for market.
The inactivated COVID-19 vaccine, developed by State-owned Sinopharm, which won conditional market approval, is safe and has an efficacy of 79 percent, the company said.
- Shanghai's shikumen complex to return to original location using small robots
- Chinese VP to attend UN Ocean Conference in France, visit Spain
- Rescue work underway after 5.0-magnitude quake hits SW China's Yunnan
- Trash or trend? Chinese enterprises recycle plastic waste into chic souvenirs
- Bullet trains streak through golden wheat fields in Shanxi
- Various events held in China to mark World Environment Day